Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04400903 · ClinicalTrials.gov registry record
Monitoring Heart Rate Variability for the Early Detection of Pancreatic Cancer
A clinical trial, sponsored by OHSU Knight Cancer Institute.
- Terminated
- Registry status
- 110
- Enrollment target
NCT04400903: Clinical Trial study, sponsored by OHSU Knight Cancer Institute.
NCT04400903 is a clinical trial that was terminated before completion, run by OHSU Knight Cancer Institute. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04400903 was terminated before completion, sponsored by OHSU Knight Cancer Institute.
- TERMINATED
- Registry status
- 110 participants
- Enrollment target
Study Summary
This study examines heart rate monitoring variability for the early detection of pancreatic cancer. Pancreatic cancer is a very difficult disease to detect early. This study is being done to observe the heart rate variability in patients with pancreatic cancer compared to undiagnosed individuals with increased risk of developing pancreatic cancer. This may help researchers determine if pancreatic occurrences/recurrences (chance of coming back) can be detected sooner through monitoring heart rate and activity.
Primary Outcome
As measured by root mean square of the successive differences (RMSSD) in pancreatic ductal adenocarcinoma (PDAC) patients and in high-risk participants.
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
- DEVICE Activity Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2020-09-21 |
| Est. Completion | 2022-09-30 |
Why NCT04400903 stopped before completion
NCT04400903 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Quality-of-Life Assessment is the first listed.
NCT04400903 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04400903 about?
NCT04400903 is a clinical study titled "Monitoring Heart Rate Variability for the Early Detection of Pancreatic Cancer". This study examines heart rate monitoring variability for the early detection of pancreatic cancer. Pancreatic cancer is a very difficult disease to detect early. This study is being done to observe the heart rate variability in patients with pancreatic cancer compared to undiagnosed individuals wit...
What is the current status of trial NCT04400903?
This trial is currently terminated. The enrollment target is 110 participants. The study started on 2020-09-21. Estimated completion is 2022-09-30.
What interventions are being tested in trial NCT04400903?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Activity Monitor (DEVICE).
Who is sponsoring clinical trial NCT04400903?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI